| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9207 |
| Human Intestinal Absorption | HIA- | 0.9770 |
| Caco-2 Permeability | Caco2- | 0.7879 |
| P-glycoprotein Substrate | Non-substrate | 0.8476 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9826 |
| Non-inhibitor | 0.9914 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9565 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7720 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7927 |
| CYP450 2D6 Substrate | Non-substrate | 0.8404 |
| CYP450 3A4 Substrate | Non-substrate | 0.7313 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9194 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9058 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9299 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9126 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9441 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9794 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9063 |
| Non-inhibitor | 0.9560 |
| AMES Toxicity | Non AMES toxic | 0.9246 |
| Carcinogens | Carcinogens | 0.5888 |
| Fish Toxicity | Low FHMT | 0.7571 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7796 |
| Honey Bee Toxicity | High HBT | 0.7666 |
| Biodegradation | Ready biodegradable | 0.5362 |
| Acute Oral Toxicity | III | 0.8068 |
| Carcinogenicity (Three-class) | Non-required | 0.6076 |